Browsing Tag
23andMe
2 posts
Regeneron to acquire 23andMe’s core assets for $256m amid court-supervised bankruptcy sale
Regeneron to acquire 23andMe’s core assets for $256M in a court-supervised deal. Learn how this biotech merger impacts DNA data privacy, investor sentiment, and the future of genetics.
May 19, 2025
23andMe cuts workforce by 40%, ends therapeutics division in drastic cost-saving measure
In a shocking turn of events, genetic testing powerhouse 23andMe announced it will slash 40% of its workforce,…
November 12, 2024